FOWEY RIVER PRACTICE — All Prescriptions & Medications — Page 12

Practice Code: L82035 | FOWEY, PL23 1DT

Showing results 551-600 of 638

MedicationItems (12m) ↓QuantityCostvs National
141,100£611+5.4% ▲
14270£393+52.1% ▲
Telmisartan13504£100-77.6% ▼
Omega-3-acid ethyl esters13728£352-38.5% ▼
Inclisiran1313£615+3.2% ▲
Loprazolam mesilate13364£282-1.8% vs avg
Rufinamide133,276£3.2K-24.3% ▼
Biphasic insulin lispro13195£1.2K-69.7% ▼
Empagliflozin/metformin13728£452-75.0% ▼
Repaglinide131,170£93-46.2% ▼
Etodolac13364£180-53.0% ▼
Dantrolene sodium133,276£526-27.9% ▼
Ciclosporin (Eye Anti Inflammatory)13390£936-47.6% ▼
Carbomer 974P13130£56+60.5% ▲
Eflornithine monohydrate chloride13780£703+85.0% ▲
Medicated stockings13130£491+92.9% ▲
Hepatitis A1313£251-82.9% ▼
13660£279-32.7% ▼
13478£262-83.8% ▼
131,020£653-15.6% ▼
13720£1.5K+18.8% ▲
Balsalazide sodium121,008£225-19.4% ▼
Linaclotide12336£428-34.3% ▼
Trimetazidine hydrochloride12720£1.2K+47.7% ▲
Dalteparin sodium1295£957-27.4% ▼
Fluvastatin sodium12336£47-48.1% ▼
Codeine phosphate122,600£49-16.4% ▼
Trimipramine maleate121,008£3.7K-24.7% ▼
Entacapone121,200£249-21.3% ▼
Rotigotine12672£3.6K-55.5% ▼
Trihexyphenidyl hydrochloride124,800£2.6K-57.7% ▼
Erythromycin12672£249-65.4% ▼
Erythromycin ethylsuccinate121,800£195-48.6% ▼
Dapsone12626£151+16.1% ▲
Biphasic insulin aspart12120£718-88.2% ▼
Somatropin1260£7.0K-15.3% ▼
Triptorelin acetate1212£736-16.3% ▼
Other health supplement preparations12360£124-74.7% ▼
Timolol and brimonidine1260£106-14.5% ▼
Hydrocortisone acetate12120£379+81.5% ▲
Co-cyprindiol (Cyprote acetate/ethinylestradiol)12756£88+38.3% ▲
12510£414-52.8% ▼
12120£84-61.5% ▼
124,800£134-52.3% ▼
1260£188-50.4% ▼
12950£105+79.4% ▲
122,460£107+33.5% ▲
12880£2.9K+2.2% ▲
12390£1.9K+27.6% ▲
123,220£750+15.3% ▲
← Back to FOWEY RIVER PRACTICE
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.